Clinical trial
Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy…
NCT00499018 · Fondazione Italiana Linfomi - ETS, Other · Unknown status
Key facts
| NCT number | NCT00499018 |
|---|---|
| Title | Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma |
| Official title | A Randomised Multicentric Phase III Study for the Treatment of Young Patients With High Risk (IPI 2-3) Diffuse Large B-Cell Lymphoma. Dose Dense Chemotherapy + Rituximab +/- Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cells. |
| Acronym | DLCL04 |
| Lead sponsor | Fondazione Italiana Linfomi - ETS, Other |
| Collaborators | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diffuse Large B-Cell Lymphoma, IPI≥2 |
| Intervention type | Drug, Procedure |
| Interventions | Rituximab, Ciclofosfamide, Doxorubicina, Vincristina, Prednisone, Pegfilgrastim, Mitoxantrone, ARA-C, Lenograstim, BCNU and 2 more |
| Enrollment | 399 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Sep 1, 2013 |
| First posted | Jul 11, 2007 |
| Last update posted | Feb 15, 2011 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: